These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 36821004)
1. BEAR: A Novel Virtual Screening Method Based on Large-Scale Bioactivity Data. Kwon Y; Park S; Lee J; Kang J; Lee HJ; Kim W J Chem Inf Model; 2023 Mar; 63(5):1429-1437. PubMed ID: 36821004 [TBL] [Abstract][Full Text] [Related]
2. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux. Desai PV; Sawada GA; Watson IA; Raub TJ Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443 [TBL] [Abstract][Full Text] [Related]
3. Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs. Matsson P; Pedersen JM; Norinder U; Bergström CA; Artursson P Pharm Res; 2009 Aug; 26(8):1816-31. PubMed ID: 19421845 [TBL] [Abstract][Full Text] [Related]
4. Development of Simplified in Vitro P-Glycoprotein Substrate Assay and in Silico Prediction Models To Evaluate Transport Potential of P-Glycoprotein. Ohashi R; Watanabe R; Esaki T; Taniguchi T; Torimoto-Katori N; Watanabe T; Ogasawara Y; Takahashi T; Tsukimoto M; Mizuguchi K Mol Pharm; 2019 May; 16(5):1851-1863. PubMed ID: 30933526 [TBL] [Abstract][Full Text] [Related]
5. Development of Ligand-based Big Data Deep Neural Network Models for Virtual Screening of Large Compound Libraries. Xiao T; Qi X; Chen Y; Jiang Y Mol Inform; 2018 Nov; 37(11):e1800031. PubMed ID: 29882343 [TBL] [Abstract][Full Text] [Related]
6. Predicting substrates of the human breast cancer resistance protein using a support vector machine method. Hazai E; Hazai I; Ragueneau-Majlessi I; Chung SP; Bikadi Z; Mao Q BMC Bioinformatics; 2013 Apr; 14():130. PubMed ID: 23586520 [TBL] [Abstract][Full Text] [Related]
7. Rapid detection of ABC transporter interaction: potential utility in pharmacology. Robey RW; Lin B; Qiu J; Chan LL; Bates SE J Pharmacol Toxicol Methods; 2011; 63(3):217-22. PubMed ID: 21112407 [TBL] [Abstract][Full Text] [Related]
8. Tetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2). Chen X; Unadkat JD; Mao Q Drug Metab Dispos; 2021 Oct; 49(10):910-918. PubMed ID: 34326138 [TBL] [Abstract][Full Text] [Related]
9. Identification of molecular fingerprints of natural products for the inhibition of breast cancer resistance protein (BCRP). Banik A; Ghosh K; Patil UK; Gayen S Phytomedicine; 2021 May; 85():153523. PubMed ID: 33662771 [TBL] [Abstract][Full Text] [Related]
10. Identification of novel breast cancer resistance protein (BCRP) inhibitors by virtual screening. Pan Y; Chothe PP; Swaan PW Mol Pharm; 2013 Apr; 10(4):1236-48. PubMed ID: 23418667 [TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis and Biological Evaluation of Quinazolinamine Derivatives as Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors with Improved Metabolic Stability. Cai CY; Teng QX; Murakami M; Ambudkar SV; Chen ZS; Korlipara VL Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830622 [TBL] [Abstract][Full Text] [Related]
12. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Allen JD; van Loevezijn A; Lakhai JM; van der Valk M; van Tellingen O; Reid G; Schellens JH; Koomen GJ; Schinkel AH Mol Cancer Ther; 2002 Apr; 1(6):417-25. PubMed ID: 12477054 [TBL] [Abstract][Full Text] [Related]
13. Structure-Based Discovery of Pyrimidine Aminobenzene Derivatives as Potent Oral Reversal Agents against P-gp- and BCRP-Mediated Multidrug Resistance. Qiu Q; Zou F; Li H; Shi W; Zhou D; Zhang P; Li T; Yin Z; Cai Z; Jiang Y; Huang W; Qian H J Med Chem; 2021 May; 64(9):6179-6197. PubMed ID: 33938746 [TBL] [Abstract][Full Text] [Related]
14. Biochemical interaction of anti-HCV telaprevir with the ABC transporters P-glycoprotein and breast cancer resistance protein. Fujita Y; Noguchi K; Suzuki T; Katayama K; Sugimoto Y BMC Res Notes; 2013 Nov; 6():445. PubMed ID: 24196382 [TBL] [Abstract][Full Text] [Related]
15. LIT-PCBA: An Unbiased Data Set for Machine Learning and Virtual Screening. Tran-Nguyen VK; Jacquemard C; Rognan D J Chem Inf Model; 2020 Sep; 60(9):4263-4273. PubMed ID: 32282202 [TBL] [Abstract][Full Text] [Related]
16. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Lee TD; Lee OW; Brimacombe KR; Chen L; Guha R; Lusvarghi S; Tebase BG; Klumpp-Thomas C; Robey RW; Ambudkar SV; Shen M; Gottesman MM; Hall MD Mol Pharmacol; 2019 Nov; 96(5):629-640. PubMed ID: 31515284 [TBL] [Abstract][Full Text] [Related]
17. Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban. Jacqueroux E; Hodin S; Saib S; He Z; Bin V; Delézay O; Delavenne X Eur J Pharm Biopharm; 2020 Mar; 148():27-37. PubMed ID: 31945490 [TBL] [Abstract][Full Text] [Related]
18. Pharmacophore Modeling Using Machine Learning for Screening the Blood-Brain Barrier Permeation of Xenobiotics. Kumar S; Deepika D; Kumar V Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294053 [TBL] [Abstract][Full Text] [Related]
19. Targeting HIV/HCV Coinfection Using a Machine Learning-Based Multiple Quantitative Structure-Activity Relationships (Multiple QSAR) Method. Wei Y; Li W; Du T; Hong Z; Lin J Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336592 [TBL] [Abstract][Full Text] [Related]